Inclusion of lipoprotein subfractions among efficacy parameters.
Superko
H R
HR
Cholesterol, Genetics, and Heart Disease Institute, Lawrence Berkeley National Laboratory, University of California, USA.
D002784:Cholesterol / Q000097:blood*; D002986:Clinical Trials as Topic / Q000379:methods*; D003324:Coronary Artery Disease / Q000097:blood* / Q000209:etiology; D015507:Drugs, Investigational; D005260:Female; D006801:Humans; D006949:Hyperlipidemias / Q000097:blood* / Q000150:complications / Q000188:drug therapy; D000960:Hypolipidemic Agents / Q000627:therapeutic use; D008297:Male; D012449:Safety
D015507:Drugs, Investigational; D000960:Hypolipidemic Agents; D002784:Cholesterol